BACKGROUND Relative wall thickness (RWT), defined as 2 times posterior wall thickness divided by the left ventricular
to reduce VA incidence, most likely through a mechanism of reverse remodeling in patients with prolonged QRS duration and left bundle branch block (LBBB) morphology (3) (4) (5) (6) .
Remodeling patterns of the LV can be assessed by echocardiographic measurement of relative wall thickness (RWT) and broadly categorized as normal or adverse remodeling, either eccentric or concentric. Previous studies have shown that concentric remodeling (high RWT) is associated with increased morbidity and mortality in hypertensive patients with hypertrophic cardiomyopathy (7) (8) (9) . However, data regarding the relation between the magnitude of eccentric hypertrophy (low RWT) and the risk of VA in patients with dilated cardiomyopathy are scarce.
The present study was carried out in 1, 260 patients with mild heart failure (HF) and Device interrogation and programming were performed as previously reported (10). All devices were programmed to monitor and deliver therapy, antitachycardia pacing, and/or shock therapy. All devices were interrogated 1 month after enrollment and thereafter every 3 months; arrhythmia episodes were adjudicated by an independent core laboratory for pre-defined categories of appropriate or inappropriate therapy. A VA episode was defined when device-rendered therapy including antitachycardia pacing or shock was appropriately delivered. Ventricular tachycardia (VT) was defined as an episode with ventricular rates between 180 and 250 beats/min; ventricular fibrillation (VF) was defined as an episode with ventricular rates >250 beats/min. Fast VT was defined as an episode with ventricular rates $200 beats/min or VF.
Echocardiograms were obtained according to a study-specific protocol at baseline, which was before device implantation, and at 1 year. Echocardiography 
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Relative wall thickness (RWT) was normally distributed among 1,260 study patients (0.26 AE 0.03). Abbreviations as in Tables 1 and 2 . All statistical tests were 2-sided, and a p value <0.05 was considered statistically significant. Analyses were carried out with SAS software version 9.4 (SAS Institute, Cary, North Carolina).
RESULTS
The baseline clinical characteristics of 1,260 study patients dichotomized into low (<0.24, lowest tertile) and high RWT ($0.24) are shown in Table 1 . (Further separation into 3 tertiles is shown in Online Table 1 ).
Patients with low RWT were younger than patients Table 2 .)
The comparison of the model fit was assessed using the AIC ( Table 2 , further detailed comparison in
Online Table 3 ). The model that included RWT as an echocardiographic measure had the best fit (lowest AIC value), thereby suggesting that RWT is the best echocardiographic variable in predicting the risk of VA compared with other commonly used echocardiographic parameters.
In a second analysis, we compared the incremental increase to the predictive value of each model when was assessed using the likelihood ratio test, whereas the Wald test was used to assess the significance of the HR for RWT (Table 3) . Accordingly, RWT was a significant and superior predictor even when combined with other echocardiographic variables and added significantly to the predictive capacity of all of the models (lower log likelihood ratio). The 2 components of RWT, LVEDD and LVPWT, were significant independent predictors of VT/VF and VT/VF/death. LVEDD was a better predictor versus LVPWT (lower AIC); however, these relationships existed in an opposite manner: whereas wider LVEDD was related to increased hazard, lower LVPWT was harmful ( Table 4) . Importantly, the model with RWT had a better fit compared with its 2 components and with the LV mass/LVEDV ratio ( Tables 2 and 4) . Table 5) . These findings were consistently significant, even after further adjustments to baseline differences (BNP, body mass index, and smoking), and in all pre-specified subgroups (Figure 3 The risk for ventricular arrhythmia (VA) was consistently and significantly higher with low relative wall thickness (RWT) in the pre-specified (Table 6) to dilated cardiomyopathy (18) . Therefore, we were able to further support previous observations and provide incremental data demonstrating that in patients with mild HF, with either ischemic or nonischemic cardiomyopathy, the magnitude of RWT (a measure of baseline eccentric hypertrophy) rather than just the categorization of LV geometry itself, could predict the risk for VA and mortality. We showed an inverse relationship between RWT and VA risk: the lower the RWT measured, the higher the risk for VA. This conclusion is also supported by our observation that among patients treated with CRT-D, a pronounced increase in RWT after 1 year (i.e., the heart becomes less "eccentric" and more normal in configuration) was associated with a significant reduction in the risk for VA or death.
Several mechanisms could potentially explain our findings. The remodeling process of the diseased heart is characterized by the replacement of necrotized myocytes with fibroblasts, which in turn increase collagen formation throughout the heart (19, 20) . This process induces fibrosis and scar formation that can potentially cause even healthy myocytes to undergo apoptosis; this paradigm is known to serve as a substrate for reentry circuits, early afterdepolarizations, and the formation of VA, especially in patients with enlarged ventricles with slowed impulse propagation velocities over fibrotic tissue (21, 22) . Additional evidence shows that fibrosis enhances the ability of oxidative stress to induce spontaneous VF (23 eccentric hypertrophy, the magnitude of RWT can mirror the extent of LV fibrosis and scarring on one hand and the extent of the remodeling process on the other hand. In the current study, both of these measures (wall thickness as a measure of wall fibrosis and diastolic diameter as a measure of remodeling)
were independently associated with the risk of VA.
Importantly, RWT had a higher predictive capacity compared with its own components. Thus, patients with very low RWT have larger LV volumes and thinner fibrotic walls, pre-disposing the patients to VA. Further studies, preferably randomized controlled clinical trials, are needed to corroborate our findings, provide better understanding of the relationship between RWT and VA, and more clearly define the evolution of RWT in patients with CRT therapy.
CONCLUSIONS
Defining the baseline degree of eccentric hypertrophy using RWT measurement can be useful for prediction of VA in patients with impaired LVEF and mild HF.
Furthermore, among patients implanted with a CRT-D device, the magnitude of RWT increase attributed to CRT-D can predict VA risk as well.
